Trust & Proof: RYBELSUS (Novo Nordisk) – Signal Evidence & AI Readability

The site avoids common trust theatre traps like unverified customer review carousels, as evidenced by a review_count of 0 across all pages. However, it relies heavily on internal summaries of studies rather than providing direct outbound proof_links_count to peer-reviewed journals or ClinicalTrials.gov identifiers in the crawled text. While the data provided is granular (e.g., 3183 adults in a CV safety study), the lack of external verification paths in the metadata increases the score slightly. The presence of a trust_theatre_flag is false, which is consistent with its clinical focus.

The proof density is high, with more than 8 distinct instances of specific clinical evidence across the pages including exact participant numbers (1864, 703, 3183) and weight loss metrics (8.4 lbs vs 8.1 lbs). Vague assertions are kept to a minimum, with most sentences serving as a delivery vehicle for a data point. The site effectively uses comparative data against named competitors like JANUVIA and JARDIANCE to establish substance.